×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App

Malaria drug touted by Trump fails to prevent Covid-19 in high profile study

The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, U.S. May 27, 2020 [Photo:Reuters]

The malaria drug promoted by U.S. President Donald Trump as a treatment for Covid-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.

The new trial found no serious side effects or heart problems from use of hydroxychloroquine.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902